Blood lymphocytes from 37 patients with systemic sclerosis were characterised using monoclonal antibodies in a two colour flow cytometric (fluorescence activated cell sorter (FACS)) analysis. A high proportion of activated T cells was also linked with impaired small intestine function but not with the degree of skin or lung involvement. A loss of suppressor inducer T cells was more pronounced later in the disease and in patients with the CREST (calcinosis, Raynaud's phenomenon, oesophageal dysmotility, sclerodactyly, telangiectasia) syndrome. These data provide further evidence for an involvement of T cell mediated immunity in the perpetuation of systemic sclerosis.
The extent to which immunological mechanisms are important in the pathogenesis of systemic sclerosis is a widely debated but still largely unresolved question. Much evidence for immunological aberrations in systemic sclerosis has been obtained from a study ofautoantibodies, and antinuclear antibodies have been shown in 60-90% of patients with this disease.' Although most of these autoantibodies are also found in other chronic inflammatory conditions, the presence of antibodies to centromeres2 3 seems to be a specific feature of a subgroup of patients with systemic sclerosis, indicating that specific immune reactions may be implicated in systemic sclerosis. An analysis of local sclerotic lesions in the skin by immunohistological methods, however, showed an infiltration of T lymphocytes and macrophages but no B cells/plasma cells,4 5 suggesting that cell mediated immunity may be more important than humoral immunity in the development of systemic sclerosis.
T and B cell activation or subset markers have so far not been widely studied in systemic sclerosis. Previous studies have indicated that the CD8+ suppressor/cytotoxic T cells are decreased and the activated T cells are increased in the disease.9 With the availability of new monoclonal antibodies and flow cytometric (fluorescence activated cell sorter (FACS)) analysis it has become possible to phenotype T cells according to functionally distinct subsets. The CD4+ subset contains helper/inducer T lymphocytes and the CD8+ subset suppressor/ cytotoxic T lymphocytes.""'2 When T cells are activated by specific antigens or mitogens they acquire surface expression of HLA-DR. ' puter (H-P, Fort Colfins, CO) with the Consort 30 software (Becton Dickinson). As controls we investigated 30 healthy individuals of both sexes aged 24-72 years, using the same markers and methods as used for the patients with scleroderma. Serum concentrations (reference ranges) of the acute phase proteins haptoglobin (0-3-2-0 g/l) and orosomucoid (0-4-1-2 g/l) and the immunoglobulins G (7-18 g/l), A (0-8-4-0 g/l), and M (0-4-2-8 gil) were measured at the department of clinical chemistry of the University Hospital, Uppsala. Erythrocyte sedimentation rate was read after one hour according to Westergren. Antinuclear antibodies were determined using rat liver sections at the department of bacteriology of the University Hospital, Uppsala. Results were considered positive if fluorescence was present at a titre > 1/25.
Statistical differences between groups and correlations were estimated by Wilcoxon's nonparametric tests. This study was performed according to principles of the Declaration of Helsinki and was approved by the local ethical committee.
Results

LYMPHOCYTE ACTIVATION AND SUBCLASS MARKER EXPRESSION IN SYSTEMIC SCLEROSIS
The percentage (mean (SD)) of circulating CD4+ lymphocytes in patients with systemic sclerosis was 51 (20)% and similar to that found in the healthy controls (53 (8)%). The CD8+ cells (mean (SD) value 21 (8)%) were significantly (p<0001) decreased compared with the controls (29 (5)%). The ratio of circulating CD4+ to CD8+ T cells was 2-8 (SD 19) in the patient group and was significantly (p<0-01) greater than that in the control group (1-9 (0 5)). Table  1 presents the lymphocyte activation and subclass marker expression in patients with systemic sclerosis and in controls. The median percentage of circulating HLA-DR+ CD4+/total CD4+ cells was 5% in patients with systemic sclerosis-that is, a 2-5-fold increase compared with the controls (p<0001). Significantly (p<0001) increased percentages of DR' CD8+/total CD8+ cells were also seen in the patient group. The proportion of circulating CD45R+ CD4+/total CD4+ cells in patients with systemic sclerosis was decreased and was, on average, half that observed in the controls (p<0-001). The lymphocyte subpopulation CDllb+ CD8+/total CD8+ cells was similar in patients and controls (table 2) .
The median number (first and third quartiles in parentheses) of circulating lymphocytes in the patients was 7 (I S-9)x107/l and in the controls [-8 ( - The antinuclear antibody titre varied between 0 and 1/3200; eight of the patients were antinuclear antibody negative-that is, had an antinuclear antibody titre <1/25. No relation was seen between the lymphocyte subpopulations and the antinuclear antibody titre. The serum concentrations of immunoglobin G (mean (SD) value 13-4 (4-5) g/l), immunoglobulin A (2-9 (1-7) g/l), or immunoglobulin M (1-6 (1 -0) g/l) did not correlate with the lymphocyte subsets. 
